Reports

Drug name	NICE TAs	Comments
Fleet Phospho-Soda
Flourescein sodium 10% injection (10 x 5ml amps)	TA274 - Ranibizumab for treating diabetic macular oedema
Fludarabine injection	TA119 - Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia TA29 - Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia
Fludarabine tablets	TA119 - Fludarabine monotherapy for the first-line treatment of chronic lymphocytic leukaemia TA29 - Guidance on the use of fludarabine for B-cell chronic lymphocytic leukaemia
Flumazenil injection
Flunarazine tablets		Not licensed in the UK. Licensed in Europe and Ireland - preventative management in primary headache.
Fluocinolone acetonide intravitreal implant (Illuvien®)	TA301 - Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema after an inadequate response to prior therapy TA590 - Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis TA953 - Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema
Fluorescein sodium Minims
Fluorouracil injection	TA212 - Bevacizumab in combination with oxaliplatin and either fluorouracil plus folinic acid or capecitabine for the treatment of metastatic colorectal cancer TA307 - Aflibercept in combination with irinotecan and fluorouracil-based therapy for treating metastatic colorectal cancer that has progressed following prior oxaliplatin-based chemotherapy	For hospital use only
Flupentixol decanoate injection		Hospital only. APC verdict - present status red. Future status amber with a framework in primary care before transfer (commissioning discussion).

First page
Previous page
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
Next page
Last page

University Hospitals Birmingham NHS Foundation Trust

Medicines Formulary

Reports